0 valutazioniIl 0% ha trovato utile questo documento (0 voti)
5 visualizzazioni1 pagina
The IDF treatment algorithm for people with type 2 diabetes recommends lifestyle measures as the first line treatment. If HbA1c levels remain above 7%, metformin is considered as the first drug option, followed by sulfonylurea or alpha-glucosidase inhibitor as second-line options. If levels are still not at target, the algorithm suggests considering basal insulin, DPP-4 inhibitors, or thiazolidinediones as third-line treatment, and combining basal and meal-time insulin or intensifying to premix insulin as fourth-line options.
The IDF treatment algorithm for people with type 2 diabetes recommends lifestyle measures as the first line treatment. If HbA1c levels remain above 7%, metformin is considered as the first drug option, followed by sulfonylurea or alpha-glucosidase inhibitor as second-line options. If levels are still not at target, the algorithm suggests considering basal insulin, DPP-4 inhibitors, or thiazolidinediones as third-line treatment, and combining basal and meal-time insulin or intensifying to premix insulin as fourth-line options.
Copyright:
Attribution Non-Commercial (BY-NC)
Formati disponibili
Scarica in formato PDF, TXT o leggi online su Scribd
The IDF treatment algorithm for people with type 2 diabetes recommends lifestyle measures as the first line treatment. If HbA1c levels remain above 7%, metformin is considered as the first drug option, followed by sulfonylurea or alpha-glucosidase inhibitor as second-line options. If levels are still not at target, the algorithm suggests considering basal insulin, DPP-4 inhibitors, or thiazolidinediones as third-line treatment, and combining basal and meal-time insulin or intensifying to premix insulin as fourth-line options.
Copyright:
Attribution Non-Commercial (BY-NC)
Formati disponibili
Scarica in formato PDF, TXT o leggi online su Scribd